pyrrolidine dithiocarbamate has been researched along with gadolinium in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carlson, CG; Samadi, A; Siegel, A | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and gadolinium
Article | Year |
---|---|
Chronic treatment with agents that stabilize cytosolic IkappaB-alpha enhances survival and improves resting membrane potential in MDX muscle fibers subjected to chronic passive stretch.
Topics: Animals; Antioxidants; Calcium Channel Blockers; Calcium Signaling; Cell Survival; Cytosol; Disease Models, Animal; Drug Administration Schedule; Female; Gadolinium; I-kappa B Proteins; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Contraction; Muscle, Skeletal; Muscular Dystrophy, Duchenne; NF-kappa B; NF-KappaB Inhibitor alpha; Pyrrolidines; Sarcolemma; Thiocarbamates | 2005 |